Clinical test data of 2.5 million people stolen from biotech company Enzo Biochem

Jonathan Greig reports:

An April ransomware attack on a biotech company resulted in the compromise of test information and personal data of nearly 2.5 million people, according to regulatory filings.

Enzo Biochem, a New York-based biosciences and diagnostics company, said that on April 6 it experienced a ransomware attack that involved the “unauthorized access to or acquisition of clinical test information of approximately 2,470,000 individuals.”

The company was able to maintain operations but discovered on April 11 that names, test information, and approximately 600,000 Social Security numbers were accessed, “and in some instances, exfiltrated from the Company’s information technology systems,” the company said in an 8-K filing with the U.S. Securities and Exchange Commission. It added that it would notify affected individuals and regulators, as required by law.

Read more at The Record.

About the author: Dissent

Comments are closed.